デフォルト表紙
市場調査レポート
商品コード
1140000

スキャフォールド技術市場:製品タイプ別、用途別、エンドユーザー別:世界の機会分析および産業予測、2021-2031年

Scaffold Technology Market By Product Type, By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: | 発行: Allied Market Research | ページ情報: 英文 254 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
スキャフォールド技術市場:製品タイプ別、用途別、エンドユーザー別:世界の機会分析および産業予測、2021-2031年
出版日: 2022年07月01日
発行: Allied Market Research
ページ情報: 英文 254 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

スキャフォールド技術の世界市場は、2021年に10億2600万米ドル、2031年には50億9530万米ドルに達し、2022年から2031年までのCAGRは18.0%を記録すると予測されています。

組織工学は、損傷した組織の一部を修復または置換する幅広い用途を対象としています。組織工学には、幹細胞、足場、シグナル伝達分子といった3つの要素があります。足場は、細胞の成長と発達、また、細胞に機械的強度を与えるために使用されます。さらに、3次元細胞培養における足場ベースのプラットフォームは、細胞が容易に3次元的成長を与えることができる表面を提供することにより、細胞培養手順を変更するために使用されます。

スキャフォールド技術では、細胞は細胞外マトリックスや合成物質の中で培養されます。細胞の接着、増殖、活性化は、足場材料の特性や足場の特徴に依存します。要求される力学的機能や新組織の形成速度を達成するためには、材料、分解速度、足場特性などのさまざまな特性を、特定の用途に合わせて変更する必要があります。

足場の孔分布、空隙率、露出表面積は、細胞外マトリックスの構造、細胞の浸透、浸透速度、再生プロセスの最終的な効果に影響を与えることができます。スキャフォールド技術の世界市場の成長は、身体再建術や組織工学の需要の増加、生体材料の使用量の増加、スキャフォールド技術の技術進歩の成長などが主な要因です。

しかし、細胞培養のための足場不要技術の導入や出現に伴う高コストが、市場成長の妨げになると予想されます。一方、新興諸国では、政府による研究開発への支出が増加しており、高い成長性が期待されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 スキャフォールド技術市場:製品タイプ別

  • 概要
    • 市場規模および予測
  • 天然足場
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別分析
  • 合成足場材
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第5章 スキャフォールド技術市場:タイプ別

  • 概要
    • 市場規模・予測
  • マクロ多孔質スカフォールド
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別分析
  • マイクロ多孔質足場材
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • ナノ多孔質足場材
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 固体足場
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第6章 スキャフォールド技術市場:用途別

  • 概要
    • 市場規模・予測
  • がん細胞調査
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 幹細胞研究
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 創薬
    • 主要な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 再生医療
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第7章 スキャフォールド技術市場:エンドユーザー別

  • 概要
    • 市場規模・予測
  • バイオ・製薬企業
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 受託研究機関
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 学術機関
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第8章 スキャフォールド技術市場:地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米市場規模推移・予測:製品タイプ別
    • 北米市場規模・予測:タイプ別
    • 北米市場規模・予測:アプリケーション別
    • 北米市場規模・予測:エンドユーザー別
    • 北米市場規模・予測:国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測:製品タイプ別
    • 欧州市場規模・予測:タイプ別
    • 欧州市場規模・予測:アプリケーション別
    • 欧州市場規模・予測:エンドユーザー別
    • 欧州市場規模・予測:国別
      • ドイツ
      • フランス
      • 英国
      • その他欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測:製品タイプ別
    • アジア太平洋地域の市場規模・予測:タイプ別
    • アジア太平洋地域の市場規模・予測:アプリケーション別
    • アジア太平洋地域の市場規模・予測:エンドユーザー別
    • アジア太平洋地域の市場規模・予測:国別
      • 日本
      • 中国
      • インド
      • オーストラリア
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測:製品タイプ別
    • LAMEAの市場規模・予測:タイプ別
    • LAMEAの市場規模・予測:アプリケーション別
    • LAMEAの市場規模・予測:エンドユーザー別
    • LAMEA市場の市場規模・予測:国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ共和国
      • LAMEAの残りの地域

第9章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第10章 企業プロファイル

  • 3D Biotek, LLC
  • Bico Group
  • Avantor, Inc.
  • Becton, Dickinson, and Company
  • Corning Incorporated
  • InSphero AG
  • Lonza Group Ltd.
  • Synthecon Incorporated
  • Thermo Fisher Scientific Inc.
  • ReproCELL Incorporated
図表

LIST OF TABLES

  • TABLE 1. GLOBAL SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 2. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR NATURAL SCAFFOLD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. SCAFFOLD TECHNOLOGY MARKET FOR NATURAL SCAFFOLD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR SYTHETIC SCAFFOLD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. SCAFFOLD TECHNOLOGY MARKET FOR SYTHETIC SCAFFOLD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. GLOBAL SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 7. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR MACRO-POROUS SCAFFOLDS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. SCAFFOLD TECHNOLOGY MARKET FOR MACRO-POROUS SCAFFOLDS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 9. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR MICRO-POROUS SCAFFOLDS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. SCAFFOLD TECHNOLOGY MARKET FOR MICRO-POROUS SCAFFOLDS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR NANO-POROUS SCAFFOLDS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. SCAFFOLD TECHNOLOGY MARKET FOR NANO-POROUS SCAFFOLDS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR SOLID SCAFFOLDS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. SCAFFOLD TECHNOLOGY MARKET FOR SOLID SCAFFOLDS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. GLOBAL SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 16. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR CANCER CELL RESEARCH, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. SCAFFOLD TECHNOLOGY MARKET FOR CANCER CELL RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR STEM CELL RESEARCH, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. SCAFFOLD TECHNOLOGY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. SCAFFOLD TECHNOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR REGENERATIVE MEDICINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 23. SCAFFOLD TECHNOLOGY MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 24. GLOBAL SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 25. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. SCAFFOLD TECHNOLOGY MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR CONTRACT RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 28. SCAFFOLD TECHNOLOGY MARKET FOR CONTRACT RESEARCH LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 29. SCAFFOLD TECHNOLOGY MARKET SIZE, FOR ACADEMIC INSTITUTES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 30. SCAFFOLD TECHNOLOGY MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 31. SCAFFOLD TECHNOLOGY MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 32. NORTH AMERICA SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 33. NORTH AMERICA SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 34. NORTH AMERICA SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 35. NORTH AMERICA SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 36. NORTH AMERICA SCAFFOLD TECHNOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 37. U.S. SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 38. U.S. SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 39. U.S. SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 40. U.S. SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 41. CANADA SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 42. CANADA SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 43. CANADA SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 44. CANADA SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 45. MEXICO SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 46. MEXICO SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 47. MEXICO SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 48. MEXICO SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 49. EUROPE SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 50. EUROPE SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 51. EUROPE SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 52. EUROPE SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 53. EUROPE SCAFFOLD TECHNOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 54. GERMANY SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 55. GERMANY SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 56. GERMANY SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. GERMANY SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 58. FRANCE SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 59. FRANCE SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 60. FRANCE SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 61. FRANCE SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 62. UNITED KINGDOM SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 63. UNITED KINGDOM SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 64. UNITED KINGDOM SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 65. UNITED KINGDOM SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 66. REST OF EUROPE SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 67. REST OF EUROPE SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 68. REST OF EUROPE SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 69. REST OF EUROPE SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 70. ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 71. ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 72. ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 73. ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 74. ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 75. JAPAN SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 76. JAPAN SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 77. JAPAN SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 78. JAPAN SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 79. CHINA SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 80. CHINA SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 81. CHINA SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 82. CHINA SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. INDIA SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 84. INDIA SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 85. INDIA SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 86. INDIA SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 87. AUSTRALIA SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 88. AUSTRALIA SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 89. AUSTRALIA SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 90. AUSTRALIA SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 94. REST OF ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 95. LAMEA SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 96. LAMEA SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 97. LAMEA SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 98. LAMEA SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 99. LAMEA SCAFFOLD TECHNOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 100. BRAZIL SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 101. BRAZIL SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 102. BRAZIL SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 103. BRAZIL SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 104. SAUDI ARABIA SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 105. SAUDI ARABIA SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 106. SAUDI ARABIA SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 107. SAUDI ARABIA SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 108. SOUTH AFRICA SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 109. SOUTH AFRICA SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 110. SOUTH AFRICA SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 111. SOUTH AFRICA SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 112. REST OF LAMEA SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
  • TABLE 113. REST OF LAMEA SCAFFOLD TECHNOLOGY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 114. REST OF LAMEA SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 115. REST OF LAMEA SCAFFOLD TECHNOLOGY MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 116.3D BIOTEK, LLC: COMPANY SNAPSHOT
  • TABLE 117.3D BIOTEK, LLC: OPERATING SEGMENTS
  • TABLE 118.3D BIOTEK, LLC: PRODUCT PORTFOLIO
  • TABLE 119.3D BIOTEK, LLC: NET SALES,
  • TABLE 120.3D BIOTEK, LLC: KEY STRATERGIES
  • TABLE 121.BICO GROUP: COMPANY SNAPSHOT
  • TABLE 122.BICO GROUP: OPERATING SEGMENTS
  • TABLE 123.BICO GROUP: PRODUCT PORTFOLIO
  • TABLE 124.BICO GROUP: NET SALES,
  • TABLE 125.BICO GROUP: KEY STRATERGIES
  • TABLE 126.AVANTOR, INC.: COMPANY SNAPSHOT
  • TABLE 127.AVANTOR, INC.: OPERATING SEGMENTS
  • TABLE 128.AVANTOR, INC.: PRODUCT PORTFOLIO
  • TABLE 129.AVANTOR, INC.: NET SALES,
  • TABLE 130.AVANTOR, INC.: KEY STRATERGIES
  • TABLE 131.BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT
  • TABLE 132.BECTON, DICKINSON, AND COMPANY: OPERATING SEGMENTS
  • TABLE 133.BECTON, DICKINSON, AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 134.BECTON, DICKINSON, AND COMPANY: NET SALES,
  • TABLE 135.BECTON, DICKINSON, AND COMPANY: KEY STRATERGIES
  • TABLE 136.CORNING INCORPORATED: COMPANY SNAPSHOT
  • TABLE 137.CORNING INCORPORATED: OPERATING SEGMENTS
  • TABLE 138.CORNING INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 139.CORNING INCORPORATED: NET SALES,
  • TABLE 140.CORNING INCORPORATED: KEY STRATERGIES
  • TABLE 141.INSPHERO AG: COMPANY SNAPSHOT
  • TABLE 142.INSPHERO AG: OPERATING SEGMENTS
  • TABLE 143.INSPHERO AG: PRODUCT PORTFOLIO
  • TABLE 144.INSPHERO AG: NET SALES,
  • TABLE 145.INSPHERO AG: KEY STRATERGIES
  • TABLE 146.LONZA GROUP LTD.: COMPANY SNAPSHOT
  • TABLE 147.LONZA GROUP LTD.: OPERATING SEGMENTS
  • TABLE 148.LONZA GROUP LTD.: PRODUCT PORTFOLIO
  • TABLE 149.LONZA GROUP LTD.: NET SALES,
  • TABLE 150.LONZA GROUP LTD.: KEY STRATERGIES
  • TABLE 151.SYNTHECON INCORPORATED: COMPANY SNAPSHOT
  • TABLE 152.SYNTHECON INCORPORATED: OPERATING SEGMENTS
  • TABLE 153.SYNTHECON INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 154.SYNTHECON INCORPORATED: NET SALES,
  • TABLE 155.SYNTHECON INCORPORATED: KEY STRATERGIES
  • TABLE 156.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 157.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 158.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 159.THERMO FISHER SCIENTIFIC INC.: NET SALES,
  • TABLE 160.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
  • TABLE 161.REPROCELL INCORPORATED: COMPANY SNAPSHOT
  • TABLE 162.REPROCELL INCORPORATED: OPERATING SEGMENTS
  • TABLE 163.REPROCELL INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 164.REPROCELL INCORPORATED: NET SALES,
  • TABLE 165.REPROCELL INCORPORATED: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.SCAFFOLD TECHNOLOGY MARKET SEGMENTATION
  • FIGURE 2.SCAFFOLD TECHNOLOGY MARKET,2021-2031
  • FIGURE 3.SCAFFOLD TECHNOLOGY MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.SCAFFOLD TECHNOLOGY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.SCAFFOLD TECHNOLOGY MARKET,BY PRODUCT TYPE,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NATURAL SCAFFOLD SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SYTHETIC SCAFFOLD SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 15.SCAFFOLD TECHNOLOGY MARKET,BY TYPE,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF MACRO-POROUS SCAFFOLDS SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MICRO-POROUS SCAFFOLDS SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF NANO-POROUS SCAFFOLDS SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SOLID SCAFFOLDS SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 20.SCAFFOLD TECHNOLOGY MARKET,BY APPLICATION,2021(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF CANCER CELL RESEARCH SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF STEM CELL RESEARCH SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF REGENERATIVE MEDICINE SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 25.SCAFFOLD TECHNOLOGY MARKET,BY END USER,2021(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF CONTRACT RESEARCH LABORATORIES SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF ACADEMIC INSTITUTES SCAFFOLD TECHNOLOGY MARKET,2021-2031(%)
  • FIGURE 29.SCAFFOLD TECHNOLOGY MARKET BY REGION,2021
  • FIGURE 30.U.S. SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 31.CANADA SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 32.MEXICO SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 33.GERMANY SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 34.FRANCE SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 35.UNITED KINGDOM SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 36.REST OF EUROPE SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 37.JAPAN SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 38.CHINA SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 39.INDIA SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 40.AUSTRALIA SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 41.REST OF ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 42.BRAZIL SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 43.SAUDI ARABIA SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 44.SOUTH AFRICA SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 45.REST OF LAMEA SCAFFOLD TECHNOLOGY MARKET,2021-2031($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50.COMPETITIVE DASHBOARD
  • FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 52.3D BIOTEK, LLC.: NET SALES ,($MILLION)
  • FIGURE 53.BICO GROUP.: NET SALES ,($MILLION)
  • FIGURE 54.AVANTOR, INC..: NET SALES ,($MILLION)
  • FIGURE 55.BECTON, DICKINSON, AND COMPANY.: NET SALES ,($MILLION)
  • FIGURE 56.CORNING INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 57.INSPHERO AG.: NET SALES ,($MILLION)
  • FIGURE 58.LONZA GROUP LTD..: NET SALES ,($MILLION)
  • FIGURE 59.SYNTHECON INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 60.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION)
  • FIGURE 61.REPROCELL INCORPORATED.: NET SALES ,($MILLION)
目次
Product Code: A11103

The global scaffold technology market was valued at $1,026.0 million in 2021, and is projected to reach $5,095.3 million by 2031, registering a CAGR of 18.0% from 2022 to 2031.

Tissue engineering covers a wide range of applications that repair or replace the portion of damaged tissue. There are three components of tissue engineering such as stem cells, scaffold, and signalizing molecules. Scaffold is used for the growth and development of cells as well as for providing mechanical strength to the cells. Moreover, scaffold-based platforms in 3D cell culture are used to alter the cell culture procedure by providing a surface on which the cells can easily impart 3D growth. 

In scaffold technology, the cells are grown within extracellular matrix or synthetic materials. Cell adhesion, proliferation, and activation depend on scaffold material properties and scaffold characteristics. To accomplish the required mechanical function and rate of new-tissue formation, different characteristics, such as materials, degradation kinetic, and scaffold properties, should be altered to match the specific application. 

Pore distribution, porosity, and exposed surface area of the scaffold can influence the architecture of the extracellular matrix, penetration, rate of penetration of cells, and the final effectiveness of regenerative process. The growth of the global scaffold technology market is majorly driven by rise in demand for body reconstruction procedures and tissue engineering, increase in usage of biomaterials, and growth of technological advancement of scaffold technology. 

However, high costs associated with implementation and emergence of scaffold-free technology for cell culturing are expected to hamper the growth of the market. On the contrary, increase in expenditure on R&D by governments in developing countries has high growth potential in these countries. 

The scaffold technology market is categorized on the basis of product type, type, application, end user, and region. Depending on product type, the market is divided into natural scaffold and synthetic scaffold. By type, the scaffold technology market is divided into macro-porous scaffolds, micro-porous scaffolds, nano-porous scaffolds, and solid scaffolds. By application, the market is fragmented into cancer cell research, stem cell research, drug discovery, and regenerative medicine. By end user, the market is classified into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

North America accounted for the largest market share in the viral clearance market in 2021 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to increase in demand for biopharmaceutical and upsurge in demand for advanced technologies in the purification of recombinant proteins produced by animal cell cultures to create high-value products of modern biotechnology.

The report provides a comprehensive competitive analysis of prominent market players such as 3D Biotek LLC, Bico Group, Agilent Technologies, Inc. (Biotek), BioVison Incorporated, Corning Incorporated, Merck KGaA (Sigmaaldrich), PromoCell GmbH, Reprocell, Incorporation, Synthecon, Incorporated, and Thermo Fisher Scientific Inc.                 

Key Benefits For Stakeholders

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2021 to 2031, which assists to identify the prevailing market opportunities. 

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

A comprehensive analysis of the factors that drive and restrain the growth of the scaffold technology market is provided.

An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

Key Market Segments

By Product Type

  • Natural Scaffold
  • Sythetic Scaffold

By Type

  • Macro-Porous Scaffolds
  • Micro-Porous Scaffolds
  • Nano-Porous Scaffolds
  • Solid Scaffolds

By Application

  • Drug discovery
  • Regenerative medicine
  • Cancer cell research
  • Stem cell research

By End User

  • Biotechnology pharmaceutical companies
  • Contract Research laboratories
  • Academic Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • 3D Biotek, LLC
    • Bico Group
    • Avantor, Inc.
    • Becton, Dickinson, and Company
    • Corning Incorporated
    • InSphero AG
    • Lonza Group Ltd.
    • Synthecon Incorporated
    • Thermo Fisher Scientific Inc.
    • ReproCELL Incorporated

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SCAFFOLD TECHNOLOGY MARKET, BY PRODUCT TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Natural Scaffold
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Sythetic Scaffold
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: SCAFFOLD TECHNOLOGY MARKET, BY TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Macro-Porous Scaffolds
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Micro-Porous Scaffolds
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Nano-Porous Scaffolds
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Solid Scaffolds
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: SCAFFOLD TECHNOLOGY MARKET, BY APPLICATION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Cancer cell research
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Stem cell research
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Drug discovery
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country
  • 6.5 Regenerative medicine
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market analysis by country

CHAPTER 7: SCAFFOLD TECHNOLOGY MARKET, BY END USER

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 Biotechnology & pharmaceutical companies
    • 7.2.1 Key market trends, growth factors and opportunities
    • 7.2.2 Market size and forecast, by region
    • 7.2.3 Market analysis by country
  • 7.3 Contract Research laboratories
    • 7.3.1 Key market trends, growth factors and opportunities
    • 7.3.2 Market size and forecast, by region
    • 7.3.3 Market analysis by country
  • 7.4 Academic Institutes
    • 7.4.1 Key market trends, growth factors and opportunities
    • 7.4.2 Market size and forecast, by region
    • 7.4.3 Market analysis by country

CHAPTER 8: SCAFFOLD TECHNOLOGY MARKET, BY REGION

  • 8.1 Overview
    • 8.1.1 Market size and forecast
  • 8.2 North America
    • 8.2.1 Key trends and opportunities
    • 8.2.2 North America Market size and forecast, by Product Type
    • 8.2.3 North America Market size and forecast, by Type
    • 8.2.4 North America Market size and forecast, by Application
    • 8.2.5 North America Market size and forecast, by End User
    • 8.2.6 North America Market size and forecast, by country
      • 8.2.6.1 U.S.
      • 8.2.6.1.1 Market size and forecast, by Product Type
      • 8.2.6.1.2 Market size and forecast, by Type
      • 8.2.6.1.3 Market size and forecast, by Application
      • 8.2.6.1.4 Market size and forecast, by End User
      • 8.2.6.2 Canada
      • 8.2.6.2.1 Market size and forecast, by Product Type
      • 8.2.6.2.2 Market size and forecast, by Type
      • 8.2.6.2.3 Market size and forecast, by Application
      • 8.2.6.2.4 Market size and forecast, by End User
      • 8.2.6.3 Mexico
      • 8.2.6.3.1 Market size and forecast, by Product Type
      • 8.2.6.3.2 Market size and forecast, by Type
      • 8.2.6.3.3 Market size and forecast, by Application
      • 8.2.6.3.4 Market size and forecast, by End User
  • 8.3 Europe
    • 8.3.1 Key trends and opportunities
    • 8.3.2 Europe Market size and forecast, by Product Type
    • 8.3.3 Europe Market size and forecast, by Type
    • 8.3.4 Europe Market size and forecast, by Application
    • 8.3.5 Europe Market size and forecast, by End User
    • 8.3.6 Europe Market size and forecast, by country
      • 8.3.6.1 Germany
      • 8.3.6.1.1 Market size and forecast, by Product Type
      • 8.3.6.1.2 Market size and forecast, by Type
      • 8.3.6.1.3 Market size and forecast, by Application
      • 8.3.6.1.4 Market size and forecast, by End User
      • 8.3.6.2 France
      • 8.3.6.2.1 Market size and forecast, by Product Type
      • 8.3.6.2.2 Market size and forecast, by Type
      • 8.3.6.2.3 Market size and forecast, by Application
      • 8.3.6.2.4 Market size and forecast, by End User
      • 8.3.6.3 United Kingdom
      • 8.3.6.3.1 Market size and forecast, by Product Type
      • 8.3.6.3.2 Market size and forecast, by Type
      • 8.3.6.3.3 Market size and forecast, by Application
      • 8.3.6.3.4 Market size and forecast, by End User
      • 8.3.6.4 Rest of Europe
      • 8.3.6.4.1 Market size and forecast, by Product Type
      • 8.3.6.4.2 Market size and forecast, by Type
      • 8.3.6.4.3 Market size and forecast, by Application
      • 8.3.6.4.4 Market size and forecast, by End User
  • 8.4 Asia-Pacific
    • 8.4.1 Key trends and opportunities
    • 8.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 8.4.3 Asia-Pacific Market size and forecast, by Type
    • 8.4.4 Asia-Pacific Market size and forecast, by Application
    • 8.4.5 Asia-Pacific Market size and forecast, by End User
    • 8.4.6 Asia-Pacific Market size and forecast, by country
      • 8.4.6.1 Japan
      • 8.4.6.1.1 Market size and forecast, by Product Type
      • 8.4.6.1.2 Market size and forecast, by Type
      • 8.4.6.1.3 Market size and forecast, by Application
      • 8.4.6.1.4 Market size and forecast, by End User
      • 8.4.6.2 China
      • 8.4.6.2.1 Market size and forecast, by Product Type
      • 8.4.6.2.2 Market size and forecast, by Type
      • 8.4.6.2.3 Market size and forecast, by Application
      • 8.4.6.2.4 Market size and forecast, by End User
      • 8.4.6.3 India
      • 8.4.6.3.1 Market size and forecast, by Product Type
      • 8.4.6.3.2 Market size and forecast, by Type
      • 8.4.6.3.3 Market size and forecast, by Application
      • 8.4.6.3.4 Market size and forecast, by End User
      • 8.4.6.4 Australia
      • 8.4.6.4.1 Market size and forecast, by Product Type
      • 8.4.6.4.2 Market size and forecast, by Type
      • 8.4.6.4.3 Market size and forecast, by Application
      • 8.4.6.4.4 Market size and forecast, by End User
      • 8.4.6.5 Rest of Asia-Pacific
      • 8.4.6.5.1 Market size and forecast, by Product Type
      • 8.4.6.5.2 Market size and forecast, by Type
      • 8.4.6.5.3 Market size and forecast, by Application
      • 8.4.6.5.4 Market size and forecast, by End User
  • 8.5 LAMEA
    • 8.5.1 Key trends and opportunities
    • 8.5.2 LAMEA Market size and forecast, by Product Type
    • 8.5.3 LAMEA Market size and forecast, by Type
    • 8.5.4 LAMEA Market size and forecast, by Application
    • 8.5.5 LAMEA Market size and forecast, by End User
    • 8.5.6 LAMEA Market size and forecast, by country
      • 8.5.6.1 Brazil
      • 8.5.6.1.1 Market size and forecast, by Product Type
      • 8.5.6.1.2 Market size and forecast, by Type
      • 8.5.6.1.3 Market size and forecast, by Application
      • 8.5.6.1.4 Market size and forecast, by End User
      • 8.5.6.2 Saudi Arabia
      • 8.5.6.2.1 Market size and forecast, by Product Type
      • 8.5.6.2.2 Market size and forecast, by Type
      • 8.5.6.2.3 Market size and forecast, by Application
      • 8.5.6.2.4 Market size and forecast, by End User
      • 8.5.6.3 South Africa
      • 8.5.6.3.1 Market size and forecast, by Product Type
      • 8.5.6.3.2 Market size and forecast, by Type
      • 8.5.6.3.3 Market size and forecast, by Application
      • 8.5.6.3.4 Market size and forecast, by End User
      • 8.5.6.4 Rest of LAMEA
      • 8.5.6.4.1 Market size and forecast, by Product Type
      • 8.5.6.4.2 Market size and forecast, by Type
      • 8.5.6.4.3 Market size and forecast, by Application
      • 8.5.6.4.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Key developments

CHAPTER 10: COMPANY PROFILES

  • 10.1 3D Biotek, LLC
    • 10.1.1 Company overview
    • 10.1.2 Company snapshot
    • 10.1.3 Operating business segments
    • 10.1.4 Product portfolio
    • 10.1.5 Business performance
    • 10.1.6 Key strategic moves and developments
  • 10.2 Bico Group
    • 10.2.1 Company overview
    • 10.2.2 Company snapshot
    • 10.2.3 Operating business segments
    • 10.2.4 Product portfolio
    • 10.2.5 Business performance
    • 10.2.6 Key strategic moves and developments
  • 10.3 Avantor, Inc.
    • 10.3.1 Company overview
    • 10.3.2 Company snapshot
    • 10.3.3 Operating business segments
    • 10.3.4 Product portfolio
    • 10.3.5 Business performance
    • 10.3.6 Key strategic moves and developments
  • 10.4 Becton, Dickinson, and Company
    • 10.4.1 Company overview
    • 10.4.2 Company snapshot
    • 10.4.3 Operating business segments
    • 10.4.4 Product portfolio
    • 10.4.5 Business performance
    • 10.4.6 Key strategic moves and developments
  • 10.5 Corning Incorporated
    • 10.5.1 Company overview
    • 10.5.2 Company snapshot
    • 10.5.3 Operating business segments
    • 10.5.4 Product portfolio
    • 10.5.5 Business performance
    • 10.5.6 Key strategic moves and developments
  • 10.6 InSphero AG
    • 10.6.1 Company overview
    • 10.6.2 Company snapshot
    • 10.6.3 Operating business segments
    • 10.6.4 Product portfolio
    • 10.6.5 Business performance
    • 10.6.6 Key strategic moves and developments
  • 10.7 Lonza Group Ltd.
    • 10.7.1 Company overview
    • 10.7.2 Company snapshot
    • 10.7.3 Operating business segments
    • 10.7.4 Product portfolio
    • 10.7.5 Business performance
    • 10.7.6 Key strategic moves and developments
  • 10.8 Synthecon Incorporated
    • 10.8.1 Company overview
    • 10.8.2 Company snapshot
    • 10.8.3 Operating business segments
    • 10.8.4 Product portfolio
    • 10.8.5 Business performance
    • 10.8.6 Key strategic moves and developments
  • 10.9 Thermo Fisher Scientific Inc.
    • 10.9.1 Company overview
    • 10.9.2 Company snapshot
    • 10.9.3 Operating business segments
    • 10.9.4 Product portfolio
    • 10.9.5 Business performance
    • 10.9.6 Key strategic moves and developments
  • 10.10 ReproCELL Incorporated
    • 10.10.1 Company overview
    • 10.10.2 Company snapshot
    • 10.10.3 Operating business segments
    • 10.10.4 Product portfolio
    • 10.10.5 Business performance
    • 10.10.6 Key strategic moves and developments